Ambac Financial Group Inc AMBC
We take great care to ensure that the data presented and summarized in this overview for AMBAC FINANCIAL GROUP INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding AMBC
View all-
Black Rock Inc. New York, NY7.21MShares$126 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.83MShares$84.8 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.87MShares$50.3 Million0.01% of portfolio
-
State Street Corp Boston, MA1.65MShares$28.9 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.09MShares$19.2 Million0.0% of portfolio
-
Repertoire Partners LP New York, NY1MShares$17.6 Million49.93% of portfolio
-
Geode Capital Management, LLC Boston, MA967KShares$17 Million0.0% of portfolio
-
Bracebridge Capital, LLC799KShares$14 Million13.28% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA797KShares$14 Million0.0% of portfolio
-
Boussard & Gavaudan Investment Management LLP London, X0683KShares$12 Million3.52% of portfolio
Latest Institutional Activity in AMBC
Top Purchases
Top Sells
About AMBC
Ambac Financial Group, Inc., a financial services holding company, provides financial guarantees in the United States, the United Kingdom, Italy, Austria, Australia, France, and Internationally. It offers financial guarantee insurance policies; specialty property & casualty program insurance; credit derivative contracts; and interest rate derivative transactions, as well as managing general agency / underwriting services. The company was incorporated in 1991 and is headquartered in New York, New York.
Insider Transactions at AMBC
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 08
2024
|
Claude Le Blanc Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,193
-0.24%
|
$17,895
$15.38 P/Share
|
Mar 08
2024
|
Claude Le Blanc Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,193
+0.24%
|
-
|
Mar 08
2024
|
David Trick Exec VP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
270
-0.18%
|
$4,050
$15.38 P/Share
|
Mar 08
2024
|
David Trick Exec VP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
270
+0.18%
|
-
|
Mar 08
2024
|
R Sharon Smith Exec VP & Chief Strategy Offr |
SELL
Payment of exercise price or tax liability
|
Direct |
233
-0.32%
|
$3,495
$15.38 P/Share
|
Mar 08
2024
|
R Sharon Smith Exec VP & Chief Strategy Offr |
BUY
Exercise of conversion of derivative security
|
Direct |
233
+0.31%
|
-
|
Mar 08
2024
|
Robert Bryan Eisman Sr. MD & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
87
-0.13%
|
$1,305
$15.38 P/Share
|
Mar 08
2024
|
Robert Bryan Eisman Sr. MD & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
87
+0.13%
|
-
|
Mar 08
2024
|
David Barranco Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,523
-2.21%
|
$37,845
$15.38 P/Share
|
Mar 08
2024
|
David Barranco Senior Managing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,001
+5.77%
|
-
|
Mar 08
2024
|
Stephen Michael Ksenak Sr. MD & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
218
-0.19%
|
$3,270
$15.38 P/Share
|
Mar 08
2024
|
Stephen Michael Ksenak Sr. MD & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
218
+0.19%
|
-
|
Mar 03
2024
|
Claude Le Blanc Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
888
-0.18%
|
$14,208
$16.19 P/Share
|
Mar 03
2024
|
Claude Le Blanc Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
888
+0.18%
|
-
|
Mar 03
2024
|
R Sharon Smith Exec VP & Chief Strategy Offr |
SELL
Payment of exercise price or tax liability
|
Direct |
179
-0.24%
|
$2,864
$16.19 P/Share
|
Mar 03
2024
|
R Sharon Smith Exec VP & Chief Strategy Offr |
BUY
Exercise of conversion of derivative security
|
Direct |
179
+0.24%
|
-
|
Mar 03
2024
|
Stephen Michael Ksenak Sr. MD & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
163
-0.15%
|
$2,608
$16.19 P/Share
|
Mar 03
2024
|
Stephen Michael Ksenak Sr. MD & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
163
+0.15%
|
-
|
Mar 03
2024
|
David Trick Exec VP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
201
-0.13%
|
$3,216
$16.19 P/Share
|
Mar 03
2024
|
David Trick Exec VP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
201
+0.13%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 10.4K shares |
---|---|
Exercise of conversion of derivative security | 37.3K shares |
Open market or private purchase | 2.5K shares |
Payment of exercise price or tax liability | 32.1K shares |
---|